NCT02946008View on ClinicalTrials.gov

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 27, 2017

Primary Completion Date

April 10, 2018

Study Completion Date

July 12, 2019

Conditions
Prostate Cancer
Interventions
RADIATION

Stereotactic Body Radiation Therapy

Delivered over 5 treatment sessions for approximately 1.5 weeks total.

PROCEDURE

Radical Prostatectomy

Open, laparoscopic, or robotic radical prostatectomy and pelvic lymph node dissection to remove the prostate, seminal vesicles, and pelvic lymph nodes.

Trial Locations (1)

48109

The University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT02946008 - Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer | Biotech Hunter | Biotech Hunter